Chong Kun Dang Pharmaceutical Corp
KRX:185750
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Price:
94 600
KRW
-1.87%
Market Cap:
₩1.3T
Relative Value
The Relative Value of one
Chong Kun Dang Pharmaceutical Corp
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 94 600 KRW,
Chong Kun Dang Pharmaceutical Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Chong Kun Dang Pharmaceutical Corp Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Chong Kun Dang Pharmaceutical Corp Competitors
Chong Kun Dang Pharmaceutical Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Chong Kun Dang Pharmaceutical Corp
KRX:185750
|
1.2T KRW | 0.7 | 21 | 11.6 | 19.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.5B USD | 15.2 | 48.1 | 32.4 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.8B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
292.8B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.2B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.9B CHF | 5.6 | 22.6 | 13.9 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.1B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 3.7 | 11.3 | 8.3 | 9.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.1B USD | 2.6 | 17.5 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
